openPR Logo
Press release

Comprehensive Juvenile Idiopathic Arthritis Diagnostic Market Forecast 2025-2034: Growth Trends and Strategic Shifts

11-21-2025 07:49 AM CET | Health & Medicine

Press release from: The Business Research Company

Juvenile Idiopathic Arthritis Diagnostic

Juvenile Idiopathic Arthritis Diagnostic

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Juvenile Idiopathic Arthritis Diagnostic Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market valuation for diagnosing juvenile idiopathic arthritis has experienced robust expansion lately, projected to advance from $4.75 billion in 2024 to $5.03 billion by 2025, reflecting a compound annual growth rate (CAGR) of 5.8%. This historical period's upward trajectory is underpinned by several factors: a rising incidence of juvenile idiopathic arthritis, heightened consciousness surrounding childhood autoimmune disorders, strides in early identification methods, augmented spending in healthcare sectors, and a greater emphasis on attending to children's medical needs.

Juvenile Idiopathic Arthritis Diagnostic Market Size Forecast: What's the Projected Valuation by 2029?
Anticipated for robust expansion over the ensuing years, the market segment dedicated to diagnosing juvenile idiopathic arthritis is projected to attain a valuation of $6.27 billion by the year 2029, reflecting a consistent annual growth rate, or CAGR, of 5.7%; this upward trajectory throughout the projection timeframe is fundamentally driven by escalating partnerships among various research bodies, a heightened requirement for prompt and precise methods of detection, the growing prevalence of inflammatory and autoimmune conditions, supportive measures undertaken by governmental and healthcare bodies, alongside the proliferation of digital health infrastructure and telemedicine applications.

View the full report here:
https://www.thebusinessresearchcompany.com/report/juvenile-idiopathic-arthritis-diagnostic-global-market-report

What Are the Drivers Transforming the Juvenile Idiopathic Arthritis Diagnostic Market?
The burgeoning occurrence of autoimmune conditions is foreseen to boost the market for diagnosing juvenile idiopathic arthritis in the foreseeable future. These disorders represent ailments where the body's defense mechanism erroneously targets its own healthy tissues, thereby inducing inflammation, structural harm, and long-term health detriment. A combination of external factors, inherent genetic tendencies, and shifts in daily habits contributes to the surge in autoimmune ailments. Autoimmune diseases initiate juvenile idiopathic arthritis (JIA) by prompting the immune response to mistakenly assault the joint's synovial lining, resulting in swelling and impairment. To illustrate, data from November 2024, sourced from Versorgungsatlas.de, a German interactive digital resource, indicated that in 2022, out of 73,241,305 individuals covered by insurance, 6,304,340 had received a diagnosis for a minimum of one autoimmune disease, yielding an unadjusted prevalence figure of 8.61%. Consequently, the expanding incidence of autoimmune disorders is serving as a catalyst for the expansion of the diagnostic sector for juvenile idiopathic arthritis.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23432&type=smp

What Long-Term Trends Will Define the Future of the Juvenile Idiopathic Arthritis Diagnostic Market?
Leading corporations within the sector for diagnosing juvenile idiopathic arthritis are prioritizing alliances to broaden their product portfolios, augment their investigative capacities, and solidify their worldwide market positioning. These tactical alliances signify cooperative agreements between entities striving to promote earlier identification and accurate diagnosis. Illustratively, in the eleventh month of 2024, Augurex Life Sciences Corp., a Canadian biotech firm, entered into an agreement with Quest Diagnostics, a diagnostics provider from the United States, with the objective of refining the diagnosis and patient care for rheumatoid arthritis (RA) through the utilization of the 14-3-3eta biomarker. Under the terms of this joint effort, Quest Diagnostics is set to validate and subsequently provide access to a lab-developed test across the United States, which utilizes Augurex's 14-3-3eta biomarker. This specific test is designed to identify elevated concentrations of the 14-3-3eta protein, known to be associated with rheumatoid arthritis, and further correlated with a higher degree of illness severity and a greater likelihood of musculoskeletal impairment.

Which Segments in the Juvenile Idiopathic Arthritis Diagnostic Market Offer the Most Profit Potential?
The juvenile idiopathic arthritis diagnosticmarket covered in this report is segmented -

1) By Type: Serological Tests; Imaging Tests; Genetic Tests
2) By Technology: Molecular Diagnostics; Immunoassays; Flow Cytometry
3) By Services: Diagnostic Services; Consultation Services; Laboratory Services
4) By Application: Hospital Laboratories; Diagnostic Centres; Research Institutes

Subsegments:
1) By Serological Tests: Rheumatoid Factor (RF) Test, Antinuclear Antibody (ANA) Test, Erythrocyte Sedimentation Rate (ESR) Test, C-Reactive Protein (CRP) Test, Anti-Cyclic Citrullinated Peptide (Anti-CCP) Test, Complete Blood Count (CBC)
2) By Imaging Tests: X-Ray, Magnetic Resonance Imaging (MRI), Ultrasound, Computed Tomography (CT) Scan, Bone Scintigraphy (Bone Scan)
3) By Genetic Tests: HLA-B27 Genetic Marker Test, Whole Exome Sequencing (WES), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR)-Based Testing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=23432&type=smp

Which Firms Dominate the Juvenile Idiopathic Arthritis Diagnostic Market by Market Share and Revenue in 2025?
Major companies operating in the juvenile idiopathic arthritis diagnostic market are Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Agilent Technologies, Sartorius AG, Sysmex Corporation, Bio-Rad Laboratories, Beckman Coulter Life Sciences, DiaSorin, Miltenyi Biotec, Cytek Biosciences, BD Biosciences, Angstrom Biotech , Sony Biotechnology, Theradiag, J. Mitra, Chimera Biotech, Stratedigm, Apogee Flow Systems, Avecon Healthcare.

Which Regions Offer the Highest Growth Potential in the Juvenile Idiopathic Arthritis Diagnostic Market?
North America was the largest region in the juvenile idiopathic arthritis diagnostic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the juvenile idiopathic arthritis diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23432

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Comprehensive Juvenile Idiopathic Arthritis Diagnostic Market Forecast 2025-2034: Growth Trends and Strategic Shifts here

News-ID: 4281785 • Views:

More Releases from The Business Research Company

What Is Driving Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Growth in 2025: The Role of The Rising Incidence Of Hematologic Disorders Accelerating Growth In The Market Due To Increasing Cases And Enhanced Diagnostic Capabilities
What Is Driving Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Marke …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Size Growth Forecast: What to Expect by 2025? The market valuation for Paroxysmal Nocturnal Hemoglobinuria (PNH) therapeutics has experienced substantial recent expansion, projected to advance from its 2024 figure of $5.35 billion to $6.07 billion in 2025, reflecting a compound annual growth rate
2025-2034 Human Metapneumovirus Diagnostics Market Evolution: Disruptions, Innovations, and Untapped Opportunities
2025-2034 Human Metapneumovirus Diagnostics Market Evolution: Disruptions, Innov …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Human Metapneumovirus Diagnostics Market Through 2025? The market encompassing human metapneumovirus diagnostics has experienced significant expansion recently, projected to increase from its 2024 valuation of $0.49 billion to $0.54 billion by 2025, reflecting a consistent compound annual growth rate of 10.0%. This
Global Glucagon-Like Peptide (GLP)-1 Agonists Weight Loss Drugs Market Projected to Grow at 16.3% CAGR, Reaching $28.3 Billion by 2029
Global Glucagon-Like Peptide (GLP)-1 Agonists Weight Loss Drugs Market Projected …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Glucagon-Like Peptide (GLP)-1 Agonists Weight Loss Drugs Industry Market Size Be by 2025? The market for glucagon-like peptide (glp)-1 agonists utilized for weight reduction has experienced swift expansion lately, projected to increase from a valuation of $13.38 billion in 2024 to $15.5 billion in 2025, reflecting
Rising Respiratory Infections Fueling Growth of the Human Metapneumovirus (hMPV) Therapeutics Market Due To Increasing Vulnerability Among Key Populations: Powering Innovation and Expansion in the Global Human Metapneumovirus (hMPV) Therapeutics Market by
Rising Respiratory Infections Fueling Growth of the Human Metapneumovirus (hMPV) …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Human Metapneumovirus (hMPV) Therapeutics Market Through 2025? The valuation of the human metapneumovirus (hmpv) therapeutics market has demonstrated robust expansion recently. Projected to advance from its 2024 figure of $0.66 billion to $0.7 billion in 2025, this trajectory reflects a compound annual

All 5 Releases


More Releases for Diagnostic

Rubella Diagnostic Testing Market Report 2024 - Rubella Diagnostic Testing Marke …
"The Business Research Company recently released a comprehensive report on the Global Rubella Diagnostic Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive
Diagnostic Electrocardiograph Market - Elevating Cardiac Care: Diagnostic Electr …
Newark, New Castle, USA: The "Diagnostic Electrocardiograph Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Diagnostic Electrocardiograph Market: https://www.growthplusreports.com/report/diagnostic-electrocardiograph-market/7804 This latest report researches the industry structure, sales, revenue,
Diagnostic Imaging Market - Empowering Precision Medicine: Harnessing the Potent …
Newark, New Castle, USA: The "Diagnostic Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2021 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Diagnostic Imaging Market: https://www.growthplusreports.com/report/diagnostic-imaging-market/7688 This latest report researches the industry structure, sales, revenue,
Rubella Diagnostic Testing Market - Advancing Rubella Control: Innovating Diagno …
Newark, New Castle, USA - new report, titled Rubella Diagnostic Testing Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Rubella Diagnostic Testing market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Rubella Diagnostic Testing market. The report offers an overview of
Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects. Tenet Diagnostics got its NABL certification in the fastest time and is
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends